ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,008Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 231

$651K Total Retail Price of All Prescriptions

Rank: 15 out of 231

423 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 423 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 423 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 9,737 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $74 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
FUROSEMIDE 354 351 1 6
AMLODIPINE BESYLATE 309 306 2 4
DONEPEZIL HCL 290 290 3 26
OMEPRAZOLE 284 275 4 5
SIMVASTATIN 273 266 5 2
NAMENDA 256 256 6 47
LEVOTHYROXINE SODIUM 242 234 7 3
PRAVASTATIN SODIUM 199 187 8 10
METOPROLOL TARTRATE 196 196 9 12
RANITIDINE HCL 188 180 10 51
ATORVASTATIN CALCIUM 185 180 11 8
SERTRALINE HCL 165 158 12 18
LISINOPRIL 165 160 12 1
QUETIAPINE FUMARATE 149 149 14 39
MIRTAZAPINE 133 133 15 25
METOLAZONE 128 128 16 141
CITALOPRAM HBR 110 106 17 20
WARFARIN SODIUM 107 107 18 17
CIPROFLOXACIN HCL 105 102 19 58
RISPERIDONE 103 103 20 34
KLOR-CON M20 101 101 21 75
SEROQUEL 94 94 22 83
DIOVAN 92 92 23 27
DIVALPROEX SODIUM 89 89 24 53
ESCITALOPRAM OXALATE 88 88 25 55
LEVOFLOXACIN 84 82 26 64
ATENOLOL 83 80 27 11
LEVETIRACETAM 83 77 27 57
CELEBREX 82 77 29 99
ALENDRONATE SODIUM 82 82 29 45
ALLOPURINOL 78 78 31 48
PERMETHRIN 78 76 31 185
CEFUROXIME 74 71 33 187
LOSARTAN POTASSIUM 74 72 33 29
CRESTOR 73 69 35 19
TAMSULOSIN HCL 69 69 36 30
AZITHROMYCIN 69 63 36 32
CLOPIDOGREL 67 67 38 44
GABAPENTIN 65 65 39 15
CARVEDILOL 63 63 40 24
METOPROLOL SUCCINATE 61 61 41 13
POLYETHYLENE GLYCOL 3350 61 56 41 36
PREDNISONE 59 59 43 41
HYDROCHLOROTHIAZIDE 59 55 43 9
CYMBALTA 59 56 43 46
TRAMADOL HCL 57 55 46 16
INSULIN SYRINGE 56 56 47 43
OLANZAPINE 55 55 48 65
AMPICILLIN TRIHYDRATE 55 55 48 218
TRAZODONE HCL 53 53 50 35
METFORMIN HCL ER 52 52 51 95
CARBIDOPA-LEVODOPA 52 52 51 73
HYDRALAZINE HCL 52 52 51 82
OXYBUTYNIN CHLORIDE ER 52 52 51 228
ISOSORBIDE MONONITRATE ER 50 50 55 56
CEPHALEXIN 50 50 55 100
PLAVIX 50 50 55 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.